Design, synthesis and biological evaluation of novel 4-phenylisoquinolinone BET bromodomain inhibito

Bennett, Michael J.; Wu, Yiqin; Boloor, Amogh; Matuszkiewicz, Jennifer; O'Connell, Shawn M.; Shi, Lihong; Stansfield, Ryan K.; Del Rosario, Joselyn R.; Veal, James M.; Hosfield, David J.; Xu, Jiangchun; Kaldor, Stephen W.; Stafford, Jeffrey A.; Betancort, Juan M.

doi:10.1016/j.bmcl.2018.04.016

Design, synthesis and biological evaluation of novel 4-phenylisoquinolinone BET bromodomain inhibito

Journal Article · 01 June 2018 · Bioorg. Med. Chem. Lett.

DOI:https://doi.org/10.1016/j.bmcl.2018.04.016· OSTI ID:1845469

Bennett, Michael J.; Wu, Yiqin; Boloor, Amogh; Matuszkiewicz, Jennifer; O'Connell, Shawn M.; Shi, Lihong; Stansfield, Ryan K.; Del Rosario, Joselyn R.; Veal, James M.; Hosfield, David J.; Xu, Jiangchun; Kaldor, Stephen W.; Stafford, Jeffrey A.; Betancort, Juan M.

Research Organization:: Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)

Sponsoring Organization:: DOE - Office Of Science; INDUSTRY

OSTI ID:: 1845469

Journal Information:: Bioorg. Med. Chem. Lett., Vol. 28, Issue (10)

Country of Publication:: United States

Language:: ENGLISH

References (28)

Bromodomains: Structure, function and pharmacology of inhibition No authors listed Biochemical Pharmacology https://doi.org/10.1016/j.bcp.2015.12.005		April 2016
The molecular hallmarks of epigenetic control No authors listed Nature Reviews Genetics https://doi.org/10.1038/nrg.2016.59		June 2016
Targeting the histone orthography of cancer: drugs for writers, erasers and readers: Histone orthography of cancer No authors listed British Journal of Pharmacology https://doi.org/10.1111/bph.12844		September 2014
Structural features and inhibitors of bromodomains No authors listed Drug Discovery Today: Technologies https://doi.org/10.1016/j.ddtec.2016.09.001		March 2016
Targeting bromodomains: epigenetic readers of lysine acetylation No authors listed Nature Reviews Drug Discovery https://doi.org/10.1038/nrd4286		April 2014
Druggability Analysis and Structural Classification of Bromodomain Acetyl-lysine Binding Sites No authors listed Journal of Medicinal Chemistry https://doi.org/10.1021/jm300346w		July 2012
Functions of bromodomain-containing proteins and their roles in homeostasis and cancer No authors listed Nature Reviews Molecular Cell Biology https://doi.org/10.1038/nrm.2016.143		January 2017
Chemical modulators for epigenome reader domains as emerging epigenetic therapies for cancer and inflammation No authors listed Current Opinion in Chemical Biology https://doi.org/10.1016/j.cbpa.2017.06.012		August 2017
Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors No authors listed Journal of Medicinal Chemistry https://doi.org/10.1021/acs.jmedchem.5b01514		April 2015
Discovery of Chemical Inhibitors of Human Bromodomains No authors listed Chemical Reviews https://doi.org/10.1021/acs.chemrev.5b00205		October 2015
Small Molecule Inhibitors of Bromodomain–Acetyl-lysine Interactions No authors listed ACS Chemical Biology https://doi.org/10.1021/cb500996u		November 2014
Drug Discovery Targeting Bromodomain-Containing Protein 4 No authors listed Journal of Medicinal Chemistry https://doi.org/10.1021/acs.jmedchem.6b01761		March 2017
Targeting Cancer Cells with BET Bromodomain Inhibitors No authors listed Cold Spring Harbor Perspectives in Medicine https://doi.org/10.1101/cshperspect.a026674		February 2017
The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins No authors listed International Journal of Molecular Sciences https://doi.org/10.3390/ijms17111849		November 2016
BET inhibitors: a novel epigenetic approach No authors listed Annals of Oncology https://doi.org/10.1093/annonc/mdx157		August 2017
Clinical progress and pharmacology of small molecule bromodomain inhibitors No authors listed Current Opinion in Chemical Biology https://doi.org/10.1016/j.cbpa.2016.05.028		August 2016
A Bead-Based Proximity Assay for BRD4 Ligand Discovery: Proximity Assay for BRD4 Ligand Discovery No authors listed Current Protocols in Chemical Biology https://doi.org/10.1002/9780470559277.ch150024		November 2015
Selective inhibition of BET bromodomains No authors listed Nature https://doi.org/10.1038/nature09504		September 2010
Discovery of N -(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1 H -pyrrolo[2,3- c ]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor No authors listed Journal of Medicinal Chemistry https://doi.org/10.1021/acs.jmedchem.7b00746		October 2017
Design, synthesis and biological evaluation of 7-methylimidazo[1,5- a ]pyrazin-8(7 H )-one derivatives as BRD4 inhibitors No authors listed Bioorganic & Medicinal Chemistry https://doi.org/10.1016/j.bmc.2017.03.008		April 2017
Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor No authors listed Journal of Medicinal Chemistry https://doi.org/10.1021/acs.jmedchem.5b01865		March 2016
Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition No authors listed Journal of Medicinal Chemistry https://doi.org/10.1021/acs.jmedchem.5b00256		April 2015
The Double Bromodomain-containing Chromatin Adaptor Brd4 and Transcriptional Regulation No authors listed Journal of Biological Chemistry https://doi.org/10.1074/jbc.R700001200		February 2007
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc No authors listed Cell https://doi.org/10.1016/j.cell.2011.08.017		September 2011
Targeting MYC dependence in cancer by inhibiting BET bromodomains No authors listed Proceedings of the National Academy of Sciences https://doi.org/10.1073/pnas.1108190108		September 2011
Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains No authors listed Journal of Medicinal Chemistry https://doi.org/10.1021/jm401088k		September 2013
Discovery and Characterization of Small Molecule Inhibitors of the BET Family Bromodomains No authors listed Journal of Medicinal Chemistry https://doi.org/10.1021/jm200108t		June 2011
Loss of the MYC gene amplified in human HL-60 cells after treatment with inhibitors of poly(ADP-ribose) polymerase or with dimethyl sulfoxide. No authors listed Proceedings of the National Academy of Sciences https://doi.org/10.1073/pnas.86.19.7442		October 1989

Similar Records

Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CL[superscript pro] covalent inhibito

Journal Article · 2022 · Eur. J. Med. Chem. · OSTI ID:1844659

Stille, Julia K.; Tjutrins, Jevgenijs; Wang, Guanyu; +17 more

Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CL[superscript pro] covalent inhibito

Journal Article · 2022 · Eur. J. Med. Chem. · OSTI ID:1845534

Stille, Julia K.; Tjutrins, Jevgenijs; Wang, Guanyu; +17 more

Design and Characterization of Novel Covalent Bromodomain and Extra-Terminal Domain (BET) Inhibitors Targeting a Methionine

Journal Article · 2021 · Journal of Medicinal Chemistry · OSTI ID:1689927

Kharenko, O; Patel, R.; Brown, S.; +6 more

Design, synthesis and biological evaluation of novel 4-phenylisoquinolinone BET bromodomain inhibito

Citation Formats

References (28)

Similar Records

Related Subjects